We examined the Nationwide Inpatient Sample (NIS) database to compare short-term postoperative outcomes following open and thoracoscopic lobectomy. Thoracoscopic (video-assisted thoracic surgery) lobectomy has been demonstrated to be associated with fewer postoperative complications compared with open thoracotomy lobectomy in several large case series. However, as no randomized trial has been performed, there are many who question this.
INTRODUCTION

Thoracoscopic lobectomy [video-assisted thoracic surgery (VATS)]
has been demonstrated to be associated with fewer postoperative complications when compared with lobectomy by thoracotomy based on the results of several large institutional cases series from select centres and a propensity-matched analysis of the Society of Thoracic Surgeons General Thoracic Database (STS-GTD). However, as no large randomized trial has been performed, there are still many who question the benefits of thoracoscopic lobectomy over conventional thoracotomy lobectomy. The applicability of thoracoscopic lobectomy is also debated, with many arguing that the technique is limited to specialized centres and not the general community [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . We queried the Nationwide Inpatient Sample (NIS) database, a large national database representing roughly 20% of all inpatient patient admissions in the USA, to compare in-hospital postoperative mortality and morbidity following open and VATS lobectomy to examine the comparative effectiveness of the VATS technique.
MATERIALS AND METHODS
Data source
The Agency for Healthcare Research and Quality (AHRQ) has maintained the NIS database since 1988. The NIS contains data on more than 8 million hospital stays from 1000 hospitals and represents roughly 20% of all hospital discharges from nongovernment institutions. Data contained within the NIS include patient and hospital demographics, admission and treating diagnoses, inpatient procedures, in-hospital mortality, length of hospital stay, hospital charges, as well as discharge status. The NIS data set has numerous internal quality measures and is validated by the Health Care Cost and Utilization Project (HCUP) by comparison with other similar databases, National Discharge Survey and the Medicare Provider Analysis and Review (http:// www.hcup-us.ahrq.gov/nisoverview.jsp). This study was approved by the Institutional Review Board Weill Cornell Medical College (Protocol No. EXE 2011-040) and conforms to the data-use agreement for the NIS from HCUP.
Patient population
The study population consists of patients (age 18 and older) who underwent lobectomy as the principal procedure either via thoracoscopy (ICD-9-CM code 32.41) or thoracotomy (ICD-9-CM codes 32.49 + 32.4) from 2007 to 2008 (two calendar years). These years were chosen as the code for thoracoscopic lobectomy (ICD-9-CM code) became available in 2007. Patients were excluded from the study if they had undergone prior thoracotomy (ICD-9-CM code 34.03), an approach other than lobectomy via thoracoscopy or thoracotomy was listed as the principal procedure, if both thoracoscopic lobectomy and thoracotomy lobectomy were listed as the approach, or thoracoscopy (ICD-9-CM code 34.21) was listed along with thoracotomy. A total of 573 patient admissions were excluded. The ICD-9-CM codes used for patient identification are summarized in Supplementary  Table 1 .
Data collection
Data collected for each patient admission included: age at the time of admission, gender, patient comorbidities, in-hospital complications, in-hospital mortality, length of stay (LOS) and discharge status. Patient comorbidities and in-hospital complications were identified from the patient's ICD-9-CM diagnosis codes. The majority of patient comorbidities were recorded using the NIS comorbidity software v3.6 format as summarized in Supplementary Table 1 [13] .
Study objectives and statistical analysis
The primary objective of this study was to compare the in-hospital mortality and morbidity of patients who underwent lobectomy either by thoracoscopy or thoracotomy approaches. We also wanted to determine risk factors for in-hospital mortality (death during hospital admission) and/or morbidity after lobectomy. SUDAAN (9.0.1) software program (Research Triangle Institute, Research Triangle Park, NC, USA) was used to convert raw counts generated from the NIS database into weighted counts that were used to generate national estimates (http://www. hcup-us.ahrq.gov/reports/methods/CalculatingNISVariances2001 06092005.pdf; http://www.hcup-us.ahrq.gov/reports/methods/ CalculatingNISVariances200106092005.pdf ). Weighted data were used for all statistical analysis.
Propensity scores were estimated using a logistic model including the following variables: age, gender, coronary artery disease, congestive heart failure, hypertension, diabetes, chronic pulmonary disease, peripheral vascular disease, chronic renal insufficiency/failure, race and hospital setting. Patients were then matched using a Greedy algorithm matching method without replacement in a roughly 1(thoracoscopic):3(thoracotomy) ratio [14] . Demographic and clinical characteristics before and after matches were expressed as median or percentages by groups. Chi-square analysis for categorical data and analysis of variance for continuous data were used to test for statistical significance. All P-values were two-sided with statistical significance evaluated at the 0.05 alpha level and are not adjusted for multiple comparisons.
Propensity scores and Greedy algorithm matching method were performed by using a macro %ONETOMANYMTCH (http:// www2.sas.com/proceedings/sugi29/165-29.pdf ) in SAS 9.2 (SAS Institute, Cary, NC, USA) [15] [16] [17] . The Greedy algorithm in this macro [15, 17] is the first to select the 'best' possible control for each case based on the propensity score [16] , and once a control is made, it is not considered again and a move is made to the 'next best' until no more matches can be made. For other analyses, the statistical package used was SPSS statistical software 17.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
Patient characteristics
Over a 2-year period, 68 350 patients underwent a lobectomy by either thoracoscopy [n = 10 554 (15%)] or thoracotomy [n = 57 796(85%)]. Thirty-two percent of thoracoscopic lobectomies (n = 3421) were performed in either rural or non-teaching urban centre, while 67.6% (n = 7133) were performed in urban teaching centre. Thoracoscopic lobectomies were performed in 276 randomly selected hospitals as per the NIS hospital sampling protocol Tables 2 and 3 .
Propensity matching in a roughly 1:3 fashion produced 10 173 patients in the thoracoscopic group and 30 866 patients in the thoracotomy group. The demographics and comorbidities of the propensity-matched group are shown in Table 1 . As designed, the demographics and comorbidities of the two cohorts are statistically similar, with the exception of the presence of diabetes, which although balanced in the unmatched cohorts was higher for those undergoing VATS (15.7 vs 13.8%, P = 0.036) in the matched analysis.
Perioperative morbidity and mortality
Analysis of the propensity-matched groups for postoperative morbidity demonstrated that thoracoscopic lobectomy was associated with significantly lower rates of postoperative complications [n = 4146 (40.8%) vs n = 13 913 (45.1%), P < 0.001]. Specifically compared with lobectomy via thoracotomy, thoracoscopic lobectomy was associated with a lower incidence of numerous cardiovascular complications including lower rates of supraventricular arrhythmias [n = 1397 (13.7%) vs n = 5536 (17.9%); P < 0.001], myocardial infarction [n = 30 (0.3%) vs n = 217 (0.7%); P = 0.011], deep venous thrombosis [n = 48 (0.5%) vs n = 303 (1.0%); P = 0.008] and pulmonary embolism [n = 57 (0.6%) vs n = 323 (1.0%); P = 0.018] ( Table 2) .
Similarly, pulmonary morbidity was significantly lower in the thoracoscopic lobectomy group for empyema [n = 79 (0.8%) vs 445 (1.4%); P = 0.007]. There were no statistically significant differences noted in rates of pneumonia or the need for mechanical or non-invasive ventilation between the two groups.
There was no difference in-hospital mortality between the patients undergoing lobectomy by thoracotomy vs those undergoing thoracoscopic lobectomy (2.3 vs 1.6%, P = 0.062) ( Table 2 ).
Length of stay and discharge status
LOS was shorter by a median of 2 days for those undergoing thoracoscopic lobectomy (median 5.0 vs 7.0 days; P < 0.001). Patients undergoing thoracoscopic lobectomy were also more frequently routinely discharged home [n = 6950 (68.3%) vs n = 19986 (64.8%); P = 0.004] ( Table 2) .
DISCUSSION
The major finding of this study is that thoracoscopic (VATS) lobectomy is associated with less morbidity than open lobectomy in a large national database. We also find that the practice of thoracoscopic lobectomy is not uncommon, with 15% of all lobectomies being performed in the USA thoracoscopically. Nor is the technique limited to teaching hospitals, with 30.3% of thoracoscopic lobectomies being performed in non-teaching centres. The importance of the continuing adoption of thoracoscopic lobectomy in the wider general thoracic surgical community cannot be overstated. With the emergence of new technologies such as stereotactic body radiotherapy for the treatment of lung cancer as well as the acceptance of lung cancer screening, thoracic surgeons will be faced with smaller lung lesions that may be amenable to these alternative treatments. When these factors are combined with the aging population with more comorbidities, thoracoscopic resectional techniques would present a better, more palatable option for many than open procedures.
The finding that thoracosopic lobectomy is superior to open lobectomy is not new. Several single-institution case series and a propensity-matched analysis of the STS-GTD have demonstrated these findings before. However, the applicability of thoracoscopic lobectomy has been debated. Many have argued that the technique can only be performed at highly select centres and hence is not reproducible in the community at large. Our study shows that the technique and its associated improved outcomes are not limited to academic teaching centres. Thoracoscopic lobectomy, though, remains underutilized with the approach used in only 15% of lobectomies performed nationally. As expected, this is lower than the 30% utilization reported in the STS-GTD in 2007 [1] . This utilization number may improve with increased numbers of thoracic surgeons graduating with specialization in general thoracic surgery.
Our findings differ from that of Gopaldas et al. who compared thoracoscopic and open lobectomy using NIS data sets from 2004 to 2006. Their principal finding was that there was no difference in morbidity or LOS between the two techniques. Thoracoscopic lobectomy was also associated with increased risk of intraoperative injury. The disparity in results may be explained by the fact that the code for thoracoscopic lobectomy became available only in 2007. In their analysis, Gopaldas et al. [12] used a thoracoscopy code as a surrogate for thoracoscopic lobectomy, which may lead to spurious data as any exploratory thoracoscopy performed prior to open lobectomy would be included as a thoracoscopic lobectomy. An alternative explanation is that since an earlier time period was examined, the early 'learning curve' of thoracoscopic lobectomy was examined. As the explicit codes for thoracoscopic lobectomy were not available in this time period, this explanation cannot be fully clarified. An additional interpretation is that the 573 patients we excluded from our analysis, which had codes for both thoracoscopic and open lobectomy, are the thoracoscopic lobectomy patients who converted for intraoperative bleeding. This is entirely possible as the rate of bleeding in this group is high (294/573). However, the NIS data set does not provide this information. As noted, our analysis is not an intention to treat analysis as in a randomized control trial and this cannot be extrapolated from the NIS. We realize that there are several other limitations to our analysis. First, this study, despite propensity matching a large cohort of patients from a national database cannot replace a randomized trial. Propensity matching in our study produced two homogenous cohorts for analysis with the exception of a higher prevalence of diabetes in the thoracoscopy lobectomy cohort. Even though the propensity scores between the groups were small and the difference between the groups is small, matching based on multiple parameters can lead to one matching parameter being slightly unbalanced. We attempted to account for this in our multivariate analysis, which demonstrates the presence of diabetes to not be a statistically significant predictor or mortality or morbidity. However, we cannot account for differences between the two groups that are not known. For example, the NIS does not capture clinical or pathological staging data and hence patients are not matched by clinical or pathological stage. Therefore, a valid criticism of this NIS analysis is that patients undergoing open lobectomy may have larger, more central tumours entailing more difficult resections and thereby affecting postoperative outcomes. Tumour characteristics including size and its central or peripheral location drive decisions towards one approach or another. Hence, tumour heterogeneity cannot be adequately controlled for between the two groups [1] . Hence, a true intention to treat analysis, as that performed in a randomized trial, cannot be performed. Furthermore, our study examines an administrative database with the analysis dependent on the quality of the data entered, especially for the postoperative morbidity. As analyses gleaned from administrative databases often affect policy, this issue has come to the forefront [18] . Missing or incomplete data entry can lead to spurious results. Also, as there are no strict guidelines from hospital to hospital for many criteria, such as discharge and postoperative care, many postoperative factors may be dependent upon hospital policy such as LOS, which may not be as robust a variable as others in this analysis. Discharge and postoperative guidelines are not available in the NIS. However, the HCUP, which maintains the NIS data set has numerous internal quality measures, and the data set is validated by comparison with other similar databases, National Discharge Survey and the Medicare Provider Analysis and Review in order to maintain the quality and consistency of the data. Furthermore, many of the findings reported in this study are in keeping with that published in other studies [1] .
In addition, our study is limited to only short-term inpatient outcomes. The NIS does not record long-term outcomes or pathological data and hence the oncological efficacy of thoracocopic lobectomy cannot be assessed. The NIS also does not capture the functional status of patients and hence quality of life measures describing postoperative recovery, such as the nature and duration of pain and return to daily activities are not known for each approach. Lastly, the specialty training and board certification of the operating surgeon are not known within the NIS data set, which may be an important determinant of quality of care in addition to patient and hospital factors. Open lobectomies performed by board certified general thoracic surgeons may have equivalent results to that of thoracoscopic lobectomy.
In conclusion, our analysis of the NIS database demonstrates that thoracoscopic lobectomy is associated with less in-hospital morbidity than open lobectomy. Thoracoscopic lobectomy is not uncommon or limited to academic teaching centres. In the absence of level one randomized data, this analysis provides data to suggest the superiority of VATS lobectomy over open lobectomy at least with respect to short-term outcomes.
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